Taste aversions in lung cancer patients treated with cytostatics
Olafsdottir, M.; Steinholtz, L.; Sjödén, P.O.
Lakartidningen 83(3): 124-125; 128-129
1986
ISSN/ISBN: 0023-7205 PMID: 3003472 Document Number: 280815
Document emailed within 1 workday
Related Documents
Rabin, B.M.; Hunt, W.A.; Lee, J. 1986: Effects of area postrema lesions on taste aversions produced by treatment with WR-2721 in the rat Neurobehavioral Toxicology and Teratology 8(1): 83-87Eshuis, M.; Verschoor, A.J.A.; Koster, T. 2011: A case of sweet taste perception caused by lung cancer-related hyponatraemia Nederlands Tijdschrift Voor Geneeskunde 155(26): A3150
Rybojad, P.ł; Dłuski, D.; Rybojad, B.; Kędra, M.; Sawicki, M.; Skoczylas, P.; Tabarkiewicz, J. 2013: Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer Annals of Agricultural and Environmental Medicine: Aaem 20(1): 101-105
Korytowska, A.; Szmeja, Z. 1993: Smell and taste in patients with chronic renal failure treated by hemodialysis Otolaryngologia Polska 47(2): 144-152
Escudero Barrilero, A.; Mateos Torres, A.; Maganto Pavón, E.; Mayayo Dehesa, T.; Allona Almagro, A.; Escribano Patiño, G.; Zubioca Ezpeleta, S.; García González, R. 1985: Intra-arterial administration of cytostatics with obstructed blood flow. Preliminary study in 7 patients with hypernephroma treated with cisplatin Revista Clinica Espanola 176(4): 187-193
Kaban, A.P.; Golovinskiĭ, B.G.; Lisetskiĭ, V.A.; Ivanova, N.O. 1983: Changes in gas exchange and tissue circulation in patients with surgically treated lung cancer Grudnaia Khirurgiia 1983(5): 34-36
Wiatr, E.; Bestry, I.; Zych, J.; Grymiński, J. 1993: Stage and regression time of radiological changes in patients treated for small cell lung cancer Pneumonologia i Alergologia Polska 61(1-2): 46-51
Pan, Y.; Wang, Y.L.; Wang, Y.G.; Wang, D.L. 2019: The pathological characteristics and outcomes of 40 surgically treated stage M1b non-small cell lung cancer patients Zhonghua Zhong Liu Za Zhi 41(1): 63-67
Cihan, Y.B. 2014: Do trace element levels have prognostic value in non-small cell lung cancer patients treated with chemoradiotherapy? Journal of Buon: Official Journal of the Balkan Union of Oncology 19(3): 749-756
Nishikawa, M.; Kusano, N.; Yoshimoto, N.; Ito, M.; Kakemizu, N.; Nozaki, M.; Fujiwara, M.; Momiyama, M.; Kido, Y. 2006: Prolonged survival of gefitinib treatment in patients with advanced and previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(10): 1437-1440
Niemiec, J.; Kołodziejski, L.; Dyczek, S.; Gasińska, A. 2004: Prognostic significance of epidermal growth factor receptor in surgically treated squamous cell lung cancer patients Folia Histochemica et Cytobiologica 42(2): 111-118
Van Binsbergen, C.J.; Hulshof, K.F.; Wedel, M.; Odink, J.; Coelingh Bennink, H.J. 1988: Food preferences and aversions and dietary pattern in anorexia nervosa patients European Journal of Clinical Nutrition 42(8): 671-678
Kamiyoshihara, M.; Hirai, T.; Kawashima, O.; Sakata, S.; Morishita, Y. 1998: Analyses on the long-term prognosis of surgical treatment for primary lung cancer in the elderly patients of 75 or over years old: how should be treated the non-recurrent death? Kyobu Geka. Japanese Journal of Thoracic Surgery 51(2): 112-115
Crvenkova, S.; Pesevska, M. 2015: Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy Journal of Buon: Official Journal of the Balkan Union of Oncology 20(3): 775-781
Levy, B.P.; Rao, P.; Becker, D.J.; Becker, K. 2016: Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors Oncology 30(7): 601-612
Horiuchi, M.; Sato, K.; Nakarai, I.; Shinoda, A. 1990: Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Pt 2): 468-474
Ishida, T.; Kaneko, S.; Akazawa, K.; Tateishi, M.; Sugio, K.; Sugimachi, K. 1993: Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients Cancer Research 53(20): 5000-5003
Xu, C.-a.; Su, H.; Liu, J.-l.; Li, L.; Zou, H.-w. 2011: Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor Zhonghua Zhong Liu Za Zhi 33(6): 436-441
Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
El-Akawi, Z.J.; Nusier, M.K.; Zoughool, F.E. 2006: Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients Saudi Medical Journal 27(2): 181-184